Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical lymphology

Microscopy Research and Technique

Volumn 55, Issue 2, 2001, Pages 122-145

  Witte, Maklys H ^a   Bernas, Michael J ^a   Martin, Clifford P ^a   Witte, Charles L ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiodysplasia; Angiogenesis; Endothelium; Lymphangiogenesis; Lymphatic; Lymphedema; Molecular lymphology; Vasculogenesis

Indexed keywords

AMINO ACIDS; BLOOD; CELL CULTURE; CELL PROLIFERATION; CHEMICAL DETECTION; DISEASE CONTROL; ENDOTHELIAL CELLS; GENE THERAPY; MICROCIRCULATION;

ANGIODYSPLASIAS; ANGIOGENESIS; ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHATIC; LYMPHOEDEMA; MOLECULAR LYMPHOLOGY; VASCULAR SYSTEM; VASCULATURE; VASCULOGENESIS;

BLOOD VESSELS;

ANGIOPOIETIN; TYROSINE KINASE RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIODYSPLASIA; ANGIOGENESIS; ARTICLE; BLOOD VESSEL; DEVELOPMENT; EXPERIMENTAL MODEL; GENE MUTATION; GENE THERAPY; GENETIC ENGINEERING; HUMAN; IMMUNOCOMPETENT CELL; LYMPH FLOW; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; LYMPHEDEMA; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL;

MURINAE;

EID: 0035886703     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1163     Document Type: Article

References (176)

1. Amaral F, Dreyer G, Figueredo-Silva J, Noroes J, CaValcanti A, Samico SC, Santos A, Continho A. 1994. Live adult worms detected by ultrasonography in human Bancroftian filariasis. Am J Trop Med Hyg 50:753-757.
2. Andres RL, Brace RA. 1990. The development of hydrops fetalis in the ovine fetus after lymphatic ligation or lymphatic excision. Am J Obstet Gynecol 162:1331-1334.
3. Aristizabal SA, Galindo JH, Davis JR, Boone ML. 1977. Lymphangiomas involving the ovary. Lymphology 10:219-223.
4. Asellius G. 1627. De Lactibus sive Lacteis Venis, Quarto Vasorum Mesarai corum Genere novo invento. Milano: J.B. Biddellium, Mediolani.
5. Banerji S, Ni J, Wang S-X, Clasper S, Su J, Tammi R, Jones M, Jackson DG. 1999. LYVE-1 a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144:789-801.
6. Baumeister RG, Frick A. 1998. Long term results of micro-lymphatic grafting. Lymphology 31(S):551-554.
7. Beckstead JH, Wood GS, Fletcher V. 1985. Evidence for origin of Kaposi's sarcoma from lymphatic endothelium. Am J Pathol 119: 294-300.
8. Bellman S, Odén B. 1958-59. Regeneration of surgically divided lymph vessels An experimental study on the rabbit's ear. Acta Chir Scand 116:99-117.
9. Bevacqua S, Welch DR, Diez de Pinos SM, Shapiro SA, Johnston MG, Witte MH, Leong SPL, Dorrance TL, Leibovitz A, Hendrix MJC. 1990. Quantitation of human melanoma, carcinoma and sarcoma tumor cell adhesion to lymphatic endothelium. Lymphology 23:4-14.
10. Bollinger A, Jäger K, Sgier F, Seglias J. 1981. Fluorescence microlymphography. Circulation 64:1195-1200.
11. Bollinger A, Isenring G, Franzech UK, Brunner U. 1983. Aplasia of superficial lymphatic capillaries in hereditary and connatal lymphedema (Milroy's disease). Lymphology 16:27-30.
12. Boris M, Weindorf S, Lasinski B. 1994. Lymphedema reduction by noninvasive complex lymphedema therapy. Oncology 8:95-106.
13. Borron P, Hay JB. 1994. Characterization of ovine lymphatic endothelial cells and their interactions with lymphocytes. Lymphology 27:6-13.
14. Bowman C, Witte MH, Witte CL, Way D, Nagle R, Copeland J, Daschbach C. 1984. Cystic hygroma reconsidered: Hamartoma or neoplasm? Primary culture of an endothelial cell line from a massive cervicomediastinal cystic hygroma with bony lymphangiomatosis. Lymphology 17:15-22.
15. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kreihuber E, Diem K, Weninger W, Tschachler E, Alitalo K, Kerjaschki D. 1909. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154: 385-394.
16. Brorson H, Svensson H. 1997. Complete reduction of lymphoedema of the arm by liposuction after breast cancer. Scand J Plast Reconstr Surg Hand Surg 31:137-143.
17. Bull LN, Roche E, Song EJ, Pedersen J, Knisely AS, van der Hagen CB, Eiklid K, Aagenaes O, Freimer NB. 2000. Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cm interval on chromosome 15q. Am J Hum Genet 67:994-999.
18. Burrows FJ, Thorpe PE. 1994. Review: vascular targeting - a new approach to the therapy of solid tumors. Pharm Ther 64:155-174.
19. Campisi C, Boccardo F. 1999. Role of microsurgery in the management of lymphoedema. Int Angio 18:47-51.
20. Carmeliet P, Jain R. 2000. Angiogenesis in cancer and other diseases. Nature 407:249-257.
21. Case TC, Witte MH, Way DL, Witte CL. 1992a. Videomicroscopy of intralymphatic-dwelling Brugia malayi. Ann Trop Med 84:435-438.
22. Case TC, Unger E, Bernas MJ, Witte MH, Witte CL, McNeill G, Crandall C, Crandall R. 1992b. Lymphatic imaging in experimental filariasis using magnetic resonance. Invest Radiol 27:293-297.
23. Case TC, Witte CL, Witte MH, Unger EC, Williams WH. 1992c. Magnetic resonance imaging in human lymphedema: Comparison with lymphangioscintigraphy. Magn Reson Imag 10:549-558.
24. Casley-Smith JR. 1983. The regenerative capacity of the lymphovascular system. In: Földi M, Casley-Smith JR, editors. Lymphangiology. Stuttgart: Schattauer. p 276-278.
25. Casley-Smith JR, Florey HW. 1961. The structure of normal small lymphatics. Q J Exp Physiol 46:101-106.
26. Casley-Smith JR, Morgan R, Piller N. 1993. Treatment of lymphedema of the arms and legs with 5,6 α benzopyrone. N Engl J Med 329:1158-1163.
27. Clark ER, Clark EL. 1932. Observations on the new growth of lymphatic vessels as seen in transparent chambers introduced into the rabbit's ear. Am J Anat 51:49-87.
28. Clodius L, Altorfer J. 1977. Experimental chronic lymphostasis of extremities. Folia Angiolog 25:137.
29. Consensus. 1995. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology Executive Committee. Lymphology 28:113-117.
30. Crandall RB, Crandall CA, Hines SA, Nayar NK. 1987. Peripheral lymphedema in ferrets infected with Brugia malayi. Am J Trop Med Hyg 37:138-142.
31. Davis S, Yancopoulos GD. 1999. The angiopoietins: yin and yang in angiogenesis. Curr Top Microbiol Immunol 237:173-185.
32. Denekamp J. 1993. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol 66:181-196.
33. Dictor M. 1988. Vascular remodeling in Kaposi's sarcoma and avian hemangiogenesis: relation to the vertebrate lymphatic system. Lymphology 21:53-60.
34. Dictor M, Carlén B, Bendsöe N, Flamholc N. 1991. Ultrastructural development of Kaposi's sarcoma in relation to the dermal microvasculature. Virchows Arch A 419:35-43.
35. Dictor M, Rambech E, Way D, Witte M, Bendsoe N. 1996. Human herpesvirus 8 (KSHV) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients: a molecular epidemiologic study. Am J Pathol 148:2009-2016.
36. Djonedi M, Brodt P. 1991. Isolation and characterization of rat lymphatic endothelial cells. Microcirc Endo Lymph 7:161-182.
37. Dorfman RF. 1988. Kaposi's sarcoma: evidence supporting its origin from the lymphatic system. Lymphology 21:45-52.
38. Drinker CK, Field MJ, Homans J. 1934. The experimental production of edema and elephantiasis as a result of lymphatic obstruction. Am J Physiol 108:509.
39. Erickson RP, Hudgins L, Stone JF, Schmidt S, Wilke C, Glover TW. 1995. A "balanced Y"; 16 translocation associated with Turner-like neonatal lymphedema suggests the location of potential anti-Turner gene on the Y chromosome. Cytogenet Cell Genet 71:163-167.
40. Evans AL, Brice G, Sotirova V, Mortimer P, Beninson J, Burnand K, Rosbotham J, Child A, Sarfarazi M. 1999. Mapping of primary congenital lymphedema to the 5q35.3 region. Am J Hum Genet 64:547-555.
41. Falls HF, Kertesz ED. 1964. A new syndrome combining pterygium colli with developmental anomalies of the eyelids and lymphatics of the lower extremities. Trans Am Ophthalmol Soc 62:248-275.
42. Fang JM, Dagenais SL, Erickson RP, Arlt MF, Glynn MW, Gorski JL, Seaver LH, Glover TW. 2000. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 67: 1382-1388.
43. Ferrara N, Alitalo K. 1999. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5:1359-1364.
44. Ferrell RE, Levinson KL, Esman JH, Kimak MA, Lawrence EC, Barmada MM, Finegold DN. 1998. Hereditary lymphedema: Evidence for linkage and genetic heterogeneity. Hum Mol Genet 7:2073-2078.
45. Földi M. 1983a. Insufficiency of lymph flow. In: Földi M, Casley-Smith JR, editors. Lymphangiology. Stuttgart: Shattauer-Verlag. p 195 (extensive review with references).
46. Földi M. 1983b. Lymphoedema. In: Földi M, Casley-Smith JR, editors. Lymphangiology. Stuttgart: Shattauer-Verlag. p 668.
47. Folkman J. 1995. Clinical applications of research on angiogenesis. N Engl J Med 26:1757-1763.
48. Gale NW, Yancopoulos GD. 1999. Growth factors acting via endothelial cell-specific tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13:1055-1066.
49. Gnepp DR, Chandler W. 1985. Tissue culture of human and canine thoracic duct endothelium. In Vitro 21:200-206.
50. Goetsch E. 1938. Hygroma colli cysticum and hygroma axillare. Arch Surg 36:394.
51. Goldstein S, Qazi QH, Fitzgerald J, Goldstein L, Friedman AP, Sawyer P. 1985. Distichiasis, congenital heart defects and mixed peripheral vascular anomalies. Am J Med Genet 20:283-394.
52. Gorham LW, Stout AP. 1955. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone). J Bone Joint Surg 37:985.
53. Greenlee R, Hoyme H, Witte M, Crowe P, Witte C. 1993. Developmental disorders of the lymphatic system. Lymphology 26:156-168.
54. Hanahan D. 1997. Signaling vascular morphogenesis and maintenance. Science 277:48-50.
55. Hendrix MJC, Seftor EA, Seftor REB, Way DL, Bernas M, Weinand M, Witte CL, Witte MH. 1994. Sex steroid modulation of endothelial cell interactions: Implications for angiodysplasia syndromes. Lymphology 27(Suppl):138-141.
56. Holberg CJ, Erickson RP, Bernas MJ, Witte MH, Fultz KE, Andrade M, Witte CL. 2001. Segregation analyses and a genome-wide linkage search confirm genetic heterogeneity and suggest oligogenic in some Milroy congenital primary lymphedema families. Am J Med Genet 98:303-312.
57. Huntington GS. 1914. The development of the mammalian jugular lymph sac, of the tributary primitive ulnar lymphatic, and of the thoracic duct from the view point of recent investigations of vertebrate lymphatic ontogeny, together with a consideration of the genetic relations of lymphatic and haemal vascular channels in the embryos of amniotes. Am J Anat 16:259-316.
58. Irrthum A, Karkkainen MJ, Devriendt K, Alito K, Vikkula M. 2000. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 67:295-301.
59. Jaffe EA. 1987. Cell biology of endothelial cells. Hum Pathol 18:234-239.
60. Jain RK. 1989. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies [review]. J Natl Cancer Inst 81: 570-576.
61. Järplid B. 1961. Haemangioendotheliomas in poultry. J Comp Pathol Ther 71:370-376.
62. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425.
63. Johnston M, Walker M. 1984. Lymphatic endothelial and smooth muscle cells in tissue culture. In Vitro 20:566-572.
64. Joukov V, Kumar V, Sorsa T, Arighi E, Weich H, Saksela O, Alitalo K. 1996a. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation and vascular permeability activities. J Biol Chem 273: 6599-6602.
65. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. 1996b. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290-298.
66. Junghans BM, Collin HB. 1989. Limbal lymphangiogenesis after corneal injury: an autoradiographic study. Curr Eye Res 8:91-100.
67. Jussila L, Valtola R, Partanen T, Salven P, Heikkila P, Matikainen M, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, Alitalo K. 1998. Lymphatic endothelium and Kaposi's sarcome spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 58:1559-1604.
68. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VWM, Fang GH, Dumont D, Breitman M, Alitalo K. 1995. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 3566-3570.
69. Kampmeier OF (ed.). 1969. Evolution and comparative morphology of the lymphatic system. Springfield, IL: Charles C. Thomas.
70. Kanter MA, Slavin SA, Kaplin W. 1990. An experimental model for chronic lymphedema. Plast Reconst Surg 85:573-580.
71. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN. 2000. Missense mutations interfere with vascular endothelial growth factor receptor-3 signaling in primary lymphedema. Nat Genet 25:153-159.
72. Kato S, Ji R, Miura M. 1998. Histochemical characteristics of endothelial cells of the subcapsular sinus in the monkey mesenteric lymph node. Lymphology 31(S):69-74.
73. Kinmonth JB, (ed.). 1972. The lymphatics: diseases, lymphography and surgery. London: Edward Arnold.
74. Ko D, Lerner R, Klose G, Cosimi A. 1998. Effective treatment of lymphedema of the extremities. Arch Surg 133:452-458.
75. Kudo T, Kato S, Simoda H, Ji R, Uchida Y. 1998. The fine distribution of the lymphatic networks in the human gallbladder. Lymphology 31(S):75-78.
76. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, Alitalo K. 1996. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122:3829-3837.
77. Leak LV. 1970. Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. Microvasc Res 2:361-391.
78. Leak L. 1985. Interaction of the peritoneal cavity to intraperitoneal stimulation: a peritoneal nodal system to monitor cellular and extracellular events in the formation of granulation tissue. Am J Anat 173:171-183.
79. Leak LV. 1991. Lymphatic endothelial cells in vitro: isolation and characterization. J Cell Biol 115:365A.
80. Leak LV, Jones M. 1993. Lymphatic endothelium isolation characterization and long term culture. Anat Rec 236:641-652.
81. Leak LV, Jones M. 1994. Lymphangiogenesis in vitro: formation of lymphatic capillary-like channels from confluent monolayers of lymphatic endothelial cells. In Vitro Cell Dev Biol 30A:512-518.
82. Leak L, Yu Z-X, Jones M, Ferrans V. 1999. Characterization of a transformed ovine lymphatic endothelial cell line. Microcirculation 6:63-73.
83. Lee-Donaldson L, Witte MH, Bernas M, Witte CL, Way D, Stea B. 1999. Refinement of a rodent model of peripheral lymphedema. Lymphology 32:111-117.
84. Leu HJ, Lie JT. 1995. Diseases of the veins and lymphatic vessels including angiodysplasias. In: Stehbens WE, Lie JT, editors. Vascular pathology. London: Chapman & Hall Medical. p 489-516.
85. Lymboussaki A, Partanen T, Olofsson B, Thomas-Crusells J, Fletcher CDM, de Waal RMW, Kaipainen A, Alitalo K 1998. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol 153:395-403.
86. Magari S. 1987. Comparison of fine structure of lymphatics and blood vessels in normal conditions and during embryonic development and regeneration. Lymphology 20:189-195.
87. Magari S, Asano S. 1978. Regeneration of the deep cervical lymphatics-light and electron microscopic observations. Lymphology 11: 57-61.
88. Makinen T, Jussila L, Veikkola T, Karpanen T, Kettunen M, Pulkkanen K, Kauppinen R, Jackson D, Kubo H, Nishikawa S-I, Yla-Herttuala S, Alitalo K. 2001. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor 3. Nat Med 7:199-205.
89. Mangion J, Rahman N, Mansour S, Brice G, Rosbotham J, Child AH, Murday VA, Mortimer PS, Barfoot R, Sigurdsson A, Edkins S, Sarfarazi M, Burnand K, Evans AL, Nunan TO, Stratton MR, Jeffery S. 1999. A gene for lymphedema-distichiasis maps to 16q24.3. Am J Human Genet 65:427-32.
90. Martin C, Suri C, Witte M, Witte C, Yancopoulos G. 2000. Imaging documentation of arrested lymphatic development in angiopoietin-2 knockout mice. FASEB J 14:A787.
91. McNeill GC, Witte MH, Witte CL, Williams WH, Hall J, Patton DD, Pond GD, Woolfenden J. 1989. Whole-body lymphangioscintigraphy: the preferred method for the initial assessment of the peripheral lymphatic system. Radiology 172:495-502.
92. Meade-Tollin L, Way D, Witte MH, Bernas M, Fiala M, Mallery S, Witte C. 1995. Constitutive metalloproteinase secretion patterns in normal, Kaposi sarcoma, and angiotumor endothelial cell populations. J Invest Med 43:311A.
93. Meade-Tollin L, Way D, Witte M. 1999. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells. Acta Histochem 101:305-316.
94. Moore P, Chang Y. 1995. Detection of herpes virus-like sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 332:1181-1185.
95. Mulliken JB, Young AE. 1988. Vascular birthmarks: hemangiomas and malformations. Philadelphia: WB Saunders.
96. Myloyde T, Witte M, Bernas M, Kriederman B, Schornack P, Unger E, Gmitro A, Gillies R, Bhujwalla Z, Witte C. 2001. Magnetic resonance imaging (MRI) of the lymphatic system: Experimental studies and clinical background. In: Witte M, editor; Chaite W, Rockson S, Bernas M, co-editors. Conquering lymphatic disease: setting the research agenda. Proceedings from an NIH Think Tank Conference, May 11-13, 2000. University of Arizona. p 181-187.
97. Nagle R, Witte MH, Witte CL, Way D. 1985. Factor VIII-associated antigen in canine lymphatic endothelium. Lymphology 18:84-85.
98. Nagle RB, Witte MH, Martinez AP, Witte CL, Hendrix MJ, Reed K, Way D. 1987. Factor VIII-associated antigen in human lymphatic endothelium. Lymphology 20:20-24.
99. Neel JV, Schull WJ. 1954. Human heredity. Chicago: University of Chicago Press. p 50-51.
100. Nicosia RF. 1987. Angiogenesis and the formation of lymphaticlike channels in cultures of thoracic duct. In Vitro Cell Dev Biol 23:167-174.
101. Odén B. 1960. A micro-lymphangiographic study of experimental wounds healing by second intention. Acta Chir Scand 120:100-114.
102. Oh S, Jeltsch MM, Birkenhäger R, McCarthy JEG, Weich HA, Christ B, Alitalo K, Wilting J. 1997. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188:96-109.
103. Olszewski W. 1973. On the pathomechanism of development of post-surgical lymphedema. Lymphology 6:35-52.
104. Olszewski WL (ed.). 1991. Lymph stasis-pathophysiology, diagnosis and treatment Boca Raton, FL: CRC Press.
105. Papendieck CM. 1992. Atlas color temas de angiologia pediatricia. Buenos Aires: Editorial Medica Panamericana.
106. Papendieck CM. 1996. Lymphangioadenodysplasias (lymphangionodaldysplasias) in pediatrics-LAAD. Lymphology 29(S):27-29.
107. Papoutsi M, Siemeister G, Weindel K, Tomarev S, Kurz H, Schächtele C, Martiny-Baron G, Christ B, Marmé D, Wilting J. 2000a. Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochem Cell Biol 114:373-385.
108. Patterson DF, Medway W, Luginbuhl H, Chacko S. 1967. Congenital hereditary lymphoedema in the dog. I. Clinical and genetic studies. J Med Genet 4:145-165.
109. Pepper MS, Wasi S, Ferrara N, Orci L, Montesano R. 1994. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Exp Cell Res 210:298-305.
110. Pepper MS. 2000. Lymphangiogenesis and tumor metastasis: more questions than answers. Lymphology 33:144-147.
111. Pittler M, Ernst E. 1998. Horse-chestnut seed extract for chronic venous insufficiency: a criteria-based systematic review. Arch Dermatol 134:1356-1360.
112. Pullinger DB, Florey HW. 1937. Proliferation of lymphatics in inflammation. J Pathol Bacteriol 45:157-170.
113. Reichert FL. 1926. The regeneration of the lymphatics. Arch Surg 13:871-881.
114. Ristimaki A, Narko K, Enholm B, Joukov V, Alitalo K. 1998. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273:8413-8418.
115. Robinow M, Johnson GF, Verhagen AD. 1970. Distichiasis-lymphoedema A hereditary syndrome of multiple congenital defects. Am J Dis Child 119:343-347.
116. Ryan TJ. 1989. Biochemical consequences of mechanical forces generated by distention and distortion. J Am Acad Dermatol 21:115-130.
117. Ryan TJ, DeBerker D. 1995. The interstitium and the connective tissue environment of the lymphatic in human skin. In: Ryan T, Mortimer PS, editors. Cutaneous lymphatic system clinics in dermatology. 13:451-458.
118. Sabin FR. 1902. On the origin and development of the lymphatic system from the veins and the development of the lymph hearts and the thoracic duct in the pig. Am J Anat 1:367-389.
119. Sauter B, Foedinger D, Sterniczky B, Wolff K, Rappersberger K. 1998. Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells: differential expression of CD31, CD34 and Type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytochem 46:165-176.
120. Schmelz S, Moll R, Kuhn C, Franke WW. 1994. Complexus adhaerentes, a new group of desmoplakin-containing junctions in endothelial cells. II. Different types of lymphatic vessels. Differentiation 57:97-117.
121. Schornack P, Myloyde T, Bhujwalla Z, Gillies R, Witte M. 2001. Imaging lymphatic anatomy and function in mouse adults and pups with Gd-albumin. Proc Intl Soc Mag Reson Med 9 (in press).
122. Schwartz JF, O'Brien MS, Hoffman Jr JS. 1980. Hereditary spinal arachnoid cysts, distichiasis, and lymphedema. Ann Neurol 7:340-343.
123. Sholley MM, Ferguson GP, Seibel HR, Montour JL, Wilson JD. 1984. Mechanisms of neovascularization: vascular sprouting can occur without proliferation of endothelial cells. Lab Invest 51: 624-634.
124. Sinzinger H, Kaliman J, Mannheimer E. 1984a. Regulation of human lymph contractility by prostaglandins and thromboxane. Lymphology 17:43-45.
125. Sinzinger H, Kaliman J, Mannheimer E. 1984b. Arachidonic acid metabolites of human lymphatics. Lymphology 17:39-42.
126. 2-liberation from human lymphatics. Lymphology 19:79-81.
127. 2-formation of human lymphatics during pulsatile perfusion. Lymphology 19:153-156.
128. 2-Walogue U-46619 and noradrenaline on contractions of the human thoracic duct. Lymphology 24:113-115.
129. Skobe M, Hawighorst T, Jackson D, Prevo R, James L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmer M. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192-198.
130. Stacker S, Caesar C, Baldwin M, Thornton G, Williams R, Prevo R, Jackson D, Nishikawa S-I, Kubo H, Achen M. 2001. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186-191.
131. Suresh S, Kumaraswami V, Suresh I. 1997. Ultrasonographic diagnosis of subclinical filariasis. J Ultrasound Med 86:435-438.
132. Tanoura T, Bernas M, Darkazanli A, Elam E, Unger E, Witte M, Green A. 1992. MR imaging in experimental lymphatic filariasis using iron-oxide compound AMI-227. Am J Roentenol 159:875-881.
133. Taylor JR, Ryu J, Colby TV, Raffin TA. 1990. Lymphangioleiomyomatosis; Clinical course in 32 patients. N Engl J Med 323: 1254-1260.
134. Thoma R. 1896. Textbook of general pathology (trans. A. Bruce), vol. 1. London: Adam and Charles Black.
135. Trevella W, Dugan MC. 1990. Endothelial interactions. In: Nishi M, Uchino S, Yabuki S, editors. Progress in lymphology-XII. Amsterdam: Elsevier Science Publishers.
136. Turner RR, Beckstead JH, Warnke RA, Wood GS. 1987. Endothelial cell diversity: in situ demonstration of immunologic and enzymatic heterogeneity that correlates with specific morphologic subtypes. Am J Clin Pathol 87:569-575.
137. Unger EC, Lund PJ, Shen DK, Fritz TA, Yellowhhair D, New TE. 1992. Nitrogen-filled liposomes as a vascular US contrast agent: preliminary evaluation. Radiology 185:453-456.
138. Unger EC, McCreery T, Sweitzer T. 1997. Ultrasound enhances gene expression of liposomal transfection. Invest Radiol 32:723-727.
139. van der Putte SCJ. 1975. The development of the lymphatic system in man. Berlin: Springer-Verlag.
140. Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, Pihlajaniemi T, Weich H, deWaal R, Alitalo K. 1999. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154:1381-1390.
141. Way D, Hendrix M, Witte M, Witte C, Nagle R, Davis J. 1987. Lymphatic endothelial cell line (CH3) from a recurrent retroperitoneal lymphangioma. In Vitro 23:647-652.
142. Way DL, Witte MH, Fiala M, Ramirez G, Nagle RB, Bernas MJ, Dictor M, Borgs P, Witte CL. 1993. Endothelial transdifferentiated phenotype and cell-cycle kinetics of AIDS-associated Kaposi sarcoma cells. Lymphology 26:79-89.
143. Weber E, Lorenzoni P, Lozzi G, Sacchi G. 1994. Differentiation between blood and lymphatic endothelium: bovine blood and lymphatic large vessels and endothelial cells in culture. J Histochem Cytochem 42:1109-1115.
144. Wigle JT, Oliver G. 1999. Prox1 function is required for the development of the murine lymphatic system. Cell 98:769-778.
145. Williams WH, Witte CL, Witte MH, McNeill GC. 2000. The nuclear medicine atlas: radionuclide lymphangioscintigraphy in the evaluation of peripheral lymphedema. Clin Nucl Med 25:451-464.
146. Wilting J, Papoutsi M, Schneider M, Christ B. 2000a. The lymphatic endothelium of the avian wing is of somitic origin. Dev Dyn 217: 271-278.
147. Wilting J, Schneider M, Papoutsi M, Alitalo K, Christ B. 2000b. An avian model for studies of embryonic lymphangiogenesis. Lymphology 33:81-94.
148. Witte CL, Corrigan JJ, Witte MH, Van Wyck DB, O'Mara RE, Woolfenden JM. 1980a. Circulatory control of splenic hyperfunction in children with peripheral blood dyscrasia. Surg Gynecol Obstet 150: 75-80.
149. Witte CL, Witte MH, Dumont AE. 1980b. Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis. Gastroenterology 78:1059-1068.
150. Witte CL, Witte MH, Dumont AE. 1984. Pathophysiology of chronic edema, lymphedema, and fibrosis. In: Staub NC, Taylor AE, editors. Edema: Basic science and clinical manifestations: a comprehensive treatise. New York: Raven Press. p 521-542.
151. Witte CL, Witte MH. 1991. Pathophysiology of lymphatic insufficiency and principles of treatment. In: Olszewski WL, editor. Lymph stasis-pathophysiology, diagnosis and treatment. Philadelphia: CRC Press. p 327-344.
152. Witte CL, Witte MH. 1999. Circulatory dynamics and pathophysiology of the lymphvascular system. In: Rutherford RB, editor. Vascular surgery, 5th ed. Philadelphia: WB Saunders. p 2110-2123.
153. Witte CL, Witte MH, Unger EC, Williams WH, Bernas MJ, McNeill GC, Stazzone A. 2000. Advances in imaging of lymph flow disorders. RadioGraphics 20:1697-1719.
154. Witte CL, Witte MH. 2001. Physiology and imaging of the lymphatic vascular system. In: Moore WS, editor. Vascular surgery; a comprehensive review, 6th ed. Philadelphia: WB Saunders (in press).
155. Witte MH, Dumont AE, Clauss RH, Rader B, Levine N, Breed ES. 1969. Lymph circulation in congestive heart failure: effect of external thoracic duct drainage. Circulation 39:723-733.
156. Witte MH, Witte CL. 1986. Lymphangiogenesis and lymphologic syndromes. Lymphology 19:21-28.
157. Witte MH, Witte CL (eds.). 1987. Are lymphatics different from blood vessels? Lymphology 20:167-276.
158. Witte MH, McNeill G, Crandall C, Case T, Witte C, Crandall Hall J, Williams W. 1988. Whole body lymphangioscintigraphy in ferrets chronically infected with Brugia malayi. Lymphology 21: 251-257.
159. Witte MH, Stuntz M, Witte CL. 1989. Kaposi's sarcoma: a lymphologic perspective. Int J Dermatol 28:561-570.
160. Witte MH, Witte CL, Way DL. 1990a. Medical ignorance, AIDS-Kaposi sarcoma complex, and the lymphatic system. West J Med 153:17-23.
161. Witte MH, Witte CL, Way DL, Fiala M. 1990b. AIDS, Kaposi sarcoma and the lymphatic system: Update and reflections. Lymphology 23:73-80.
162. Witte MH, Jamal S, Williams W, Witte CL, Kumaraswami V, McNeill G, Case T, Panicker TMR. 1993. Lymphatic abnormalities in human filariasis as depicted by lymphangioscintigraphy. Arch Intern Med 153:737-744.
163. Witte MH, Witte CL. 1995. Epilogue: beyond the sphere of knowledge in lymphology. In: Ryan T, Mortimer PS, editors. Cutaneous lymphatic system. Clin Dermatol 13:511-514.
164. Witte MH, Witte CL. 1997a. On tumor (and other) lymphangiogenesis [editorial]. Lymphology 30:1-2.
165. Witte MH, Erickson R, Reiser FA, Witte CL. 1997b. Genetic alterations in lymphedema. Phlebolymphology 16:19-25.
166. Witte MH, Way DL, Witte CL, Bernas M. 1997c. Lymphangiogenesis: mechanisms, significance and clinical implications. In: Goldberg ID, Rosen EM, editors. Regulation of angiogenesis. Basel: Birkhaueser Verlag. p 65-112.
167. Witte MH, Erickson R, Bernas M, Andrade M, Reiser F, Conlon W, Hoyme HE, Witte CL. 1998a. Phenotypic and genotypic heterogeneity in familial Milroy lymphedema. Lymphology 31:145-155.
168. Witte MH, Witte CL, Way D, Bernas M. 1998b. Control of lymphangiogenesis. In: Jiménez Cossío JA, Farrajota A, Samaniego E, Witte MH, Witte CL, editors. Progress in lymphology XVI. Lymphology 31(S):37-40.
169. Witte MH, Witte CL, Bernas M. 1998c. ISL Consensus document revisited: suggested modifications. Lymphology 31:138-140.
170. Witte MH (ed.); Chaite W, Rockson S, Bernas M (co-eds.). 2001. Conquering lymphatic disease: setting the research agenda. Proceedings from an NIH Think Tank Conference, May 11-13, 2000. University of Arizona; 2001.
171. Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, Principe N, Kearney M, Hu J-S, Isner J. 1998. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 153:381-394
172. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. 2000. Vascular-specific growth factors and blood vessel formation Nature 407:242-247.
173. Yoffey JM, Courtice FC (eds.). 1970. Lymphatics, lymph and the lymphomyeloid complex. London: Academic Press.
174. Yong LC, Jones B. 1991. A comparison study of cultured vascular and lymphatic endothelium. Exp Pathol 42:11-25.
175. Zetter BR. 1987. Endothelial heterogeneity: influence of vessel size, organ localization, and species specificity on the properties of cultured endothelial cells. In: Ryan US, editor. Endothelial cells, vol II. Boca Raton, FL: CRC Press. p 63-80.
176. Ziehe M, Morbidelli L, Alessandri G, Guillino PM. 1992. Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. Lab Invest 67:711-715.